Novyy podkhod v formirovanii dostupa k krovenosnomu ruslu pri gemodialize

References

[1] Huber T.S., Buhler A.G., Seeger JM. Evidence-based data for the hemodialysis access surgeon. Semin. Dial. 20D4; 3: 217-23.

[2] Besarab A. Access monitoring is worthwhile and valuable. Blood Purif. 2006; 24: 77-84.

[3] Allon M., Robbin M.L. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney 2002; 62(4): 1109-24.

[4] Allon M. Current Management of Vascular Access. Clin. J. Am. Soc. Nephrol. 2007; 2: 786-800.

[5] Rocco M.V., Bleyer A.J., Burkart J.M. Utilization of inpatient and outpatient resources for the management of hemodialysis access complications. Am. J. Kidney. Dis. 1ЭЭ6; 28: 250-6.

[6] Weinberg C.B., Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986; 231:397-400.

[7] Shin'oka Т., Imai Y., Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N. Engl. J. Med. 2001; 344: 532-33.

[8] 8. L'Heureux N., Dusserre N., Konig G. et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat. Med. 2006; 12: 361-5.

[9] McAllister T.N., Maruszewski M., Garrido S.A. et al. E-ectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009; 373: 1440-6.

RIGHTS & PERMISSIONS

Eco-Vector